ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: This allowed the detection of the mutant mRNA with a high degree of accuracy, and thus enabled the separation of human HSPCs from chronic myeloid leukemia (CML) patients into BCR-ABL+ and BCR-ABL−.